feed,title,long_url,short_url
Benzinga,Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment,https://benzinga.com/news/22/08/28616436/glaukos-inks-licensing-pact-for-rare-eye-disorder-treatment,https://bit.ly/3PQ4xSu
Benzinga,Akero Lead Candidate Improves Fibrosis In Cirrhotic NASH Patients,https://benzinga.com/general/biotech/22/08/28616821/akero-lead-candidate-improves-fibrosis-in-cirrhotic-nash-patients,https://bit.ly/3KjneNp
